Purchases and Sales Made in Q3 2024 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q3 2024. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-187- 0.24% |
$806 - $1.12K
|
76.8K
$73.7K
|
|
|
Nov 13, 2024
Q3 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-727- 3.39% |
$3.13K - $4.36K
|
20.7K
$19.9K
|
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-981- 5.98% |
$4.23K - $5.89K
|
15.4K
$14.8K
|
|
|
Oct 23, 2024
Q3 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-2.37K- 13.9% |
$10.2K - $14.2K
|
14.7K
$14.1K
|
|
|
Nov 12, 2024
Q3 2024
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-3.7K- 7.67% |
$16K - $22.2K
|
44.6K
$42.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.72K- 72.36% |
$20.3K - $28.3K
|
1.8K
$1.73K
|
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-4.97K- 0.19% |
$21.4K - $29.8K
|
2.62M
$2.52M
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-5.3K- 17.91% |
$22.8K - $31.8K
|
24.3K
$23.3K
|
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-5.53K- 13.51% |
$23.8K - $33.2K
|
35.4K
$34K
|
|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-7.13K- 12.92% |
$30.7K - $42.8K
|
48.1K
$46.1K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-18.4K- 13.15% |
$79.3K - $110K
|
122K
$117K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-23K- 12.27% |
$99.3K - $138K
|
165K
$158K
|
|
|
Nov 13, 2024
Q3 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-33.9K- 1.19% |
$146K - $204K
|
2.82M
$2.71M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-43.5K- 2.43% |
$187K - $261K
|
1.74M
$1.67M
|
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-55.2K- 0.96% |
$238K - $331K
|
5.67M
$5.45M
|
|
|
Nov 14, 2024
Q3 2024
|
Samlyn Capital, LLC
New York, NY |
SELL
|
- |
-91.4K- 2.73% |
$394K - $548K
|
3.26M
$3.13M
|
|
|
Nov 14, 2024
Q3 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-272K- 18.57% |
$1.17M - $1.63M
|
1.19M
$1.14M
|